Its role is to: Enhance insulin secretion when blood sugar rises Reduce glucagon secretion , lowering blood glucose production Slow stomach emptying , which promotes satiety Reduce appetite , leading to weight loss Since natural GLP-1 breaks down quickly, drug companies created synthetic GLP-1 receptor agonists (like semaglutide in Ozempic/Wegovy) that stay active longer
Positive reviews note the affordability and availability of compounded GLP-1s at a time when brand-name access was limited, and some patients report meaningful weight loss results
Most injectable peptides require refrigerated storage, protection from light, and reconstitution with bacteriostatic water using sterile technique
Influence of age and sex on alcohol pharmacokinetics and subjective pharmacodynamic responses following intravenous alcohol exposure in humans [online]
It's worth noting that GLP-1 receptor agonists should be used with caution in people with severe gastrointestinal disease, including severe gastroparesis, as these conditions may be exacerbated by further slowing of gastric emptying